四、后果 瘦型NAFLD可能更严重
五、一旦怀疑诊断瘦型脂肪肝 应该做哪些检查?
关于检查,AGA专家共识是这样推荐的:
无症状无风险的瘦型人群并不都需要常规筛查脂肪肝,但一旦疑诊为瘦型脂肪肝,根据AGA指南建议,还需要完善以下四个维度的检查:
FIB-4=年龄×AST/ PLT×√ALT 六、如何用药?
目前无特效药可以预防或治疗脂肪肝,指南推荐药物属于辅助治疗。脂肪肝逆转主要依赖饮食结构调整及运动锻炼。 关于用药,AGA专家共识中这样建议:
七、如何管理 瘦型脂肪肝不需要控制饮食么?
封面来源:Image by brgfx on Freepik 参考文献: 1.Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K, Serfaty L. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study). Hepatology. 2023 Feb 24. doi: 10.1097/HEP.0000000000000329. Epub ahead of print. PMID: 36815354. 2.Hagström H, Nasr P, Ekstedt M, Hammar U, Stål P, Hultcrantz R, Kechagias S. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study. Hepatol Commun. 2017 Nov 30;2(1):48-57. doi: 10.1002/hep4.1124. PMID: 29404512; PMCID: PMC5776871. 3.VanWagner LB, Armstrong MJ. Lean NAFLD: A not so benign condition? Hepatol Commun. 2018 Jan 16;2(1):5-8. doi: 10.1002/hep4.1143. PMID: 29404505; PMCID: PMC5776877. 4.Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, Chien N, Trinh S, Henry L, Stave CD, Hosaka T, Cheung RC, Nguyen MH. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12. PMID: 32413340. 5.Long MT, Noureddin M, Lim JK. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review. Gastroenterology. 2022 Sep;163(3):764-774.e1. doi: 10.1053/j.gastro.2022.06.023. Epub 2022 Jul 14. PMID: 35842345; PMCID: PMC9398982. 6.Do A, Lim JK. Lean NAFLD is associated with adverse liver events and mortality: moving beyond BMI. Hepatology. 2023 Mar 13. doi: 10.1097/HEP.0000000000000360. Epub ahead of print. PMID: 36896961. 7.Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther. 2017 Jul;46(2):85-95. doi: 10.1111/apt.14112. Epub 2017 May 2. PMID: 28464369. 8.阿儒汗,贾海燕,丁艳华,牛俊奇.瘦型非酒精性脂肪性肝病的研究进展[J].临床肝胆病杂志,2020,36(5):1154-1159 转载自:华润三九润达夫平台 |